XML 25 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2023
Sep. 24, 2022
Sep. 25, 2021
OPERATING ACTIVITIES      
Net income $ 456,000,000.0 $ 1,302,000,000 $ 1,869,700,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 89,600,000 89,200,000 88,000,000.0
Amortization of acquired intangible assets 233,800,000 340,900,000 318,900,000
Stock-based compensation expense 79,600,000 66,700,000 65,000,000.0
Deferred income taxes and other non-cash taxes (109,100,000) (166,200,000) (70,100,000)
Impairment of intangible assets and equipment 223,800,000 45,100,000 0
Loss on assets held-for-sale 51,700,000 0 0
Increase in contingent consideration liability (14,900,000) (39,500,000) (6,700,000)
Debt extinguishment loss 0 700,000 21,600,000
Other adjustments and non-cash items 28,900,000 32,600,000 31,000,000.0
Changes in operating assets and liabilities, excluding the effect of acquisitions:      
Accounts receivable (1,500,000) 272,300,000 110,900,000
Inventory (4,900,000) (136,600,000) (84,100,000)
Prepaid income taxes 17,400,000 (23,300,000) 13,000,000.0
Prepaid expenses and other assets 23,600,000 384,300,000 (56,300,000)
Accounts payable (23,000,000.0) (14,400,000) 20,400,000
Accrued expenses and other liabilities (14,200,000) (15,800,000) (4,900,000)
Deferred revenue 14,400,000 (12,300,000) 14,000,000.0
Net cash provided by operating activities 1,051,200,000 2,125,700,000 2,330,400,000
INVESTING ACTIVITIES      
Acquisition of businesses, net of cash acquired (5,000,000.0) (158,600,000) (1,164,700,000)
Capital expenditures (91,800,000) (70,600,000) (118,300,000)
Proceeds received from government grants for capacity expansion 20,500,000 75,000,000.0 21,500,000
Increase in equipment under customer usage agreements (58,400,000) (56,600,000) (59,400,000)
Purchase of equity method investment (10,000,000.0) 0 0
Payments to Acquire Intangible Assets 0 0 (6,500,000)
Other activity (7,400,000) 4,500,000 (2,200,000)
Net cash used in investing activities (152,100,000) (206,300,000) (1,329,600,000)
FINANCING ACTIVITIES      
Proceeds from long-term debt, net of issuance costs 0 1,491,200,000 0
Repayment of long-term debt (15,000,000.0) (1,387,500,000) (75,000,000.0)
Proceeds from Senior Notes 0 0 936,300,000
Repayment of Senior Notes 0 0 (970,800,000)
Repayments under revolving credit line 0 0 (250,000,000.0)
Proceeds from accounts receivable securitization agreement 0 0 320,000,000.0
Repayments under accounts receivable securitization agreement 0 (248,500,000) (71,500,000)
Repayment of acquired debt 0 (63,700,000) 0
Payments to Noncontrolling Interests 0 0 (8,500,000)
Payment for Contingent Consideration Liability, Financing Activities (7,600,000) (12,200,000) 0
Payments For Deferred Acquisition Consideration (800,000) 0 (1,900,000)
Repurchases of common stock (474,800,000) (542,100,000) (409,800,000)
Net proceeds from issuance of common stock under employee stock plans 43,000,000.0 33,500,000 51,300,000
Payment of minimum tax withholdings on net share settlements of equity awards (24,000,000.0) (22,900,000) (47,500,000)
Payments under finance lease obligations (4,000,000.0) (3,800,000) (2,400,000)
Net cash used in financing activities (483,200,000) (756,000,000.0) (529,800,000)
Effect of exchange rate changes on cash and cash equivalents 300,000 5,800,000 (1,700,000)
Net increase in cash and cash equivalents 416,200,000 1,169,200,000 469,300,000
Cash and cash equivalents, beginning of period 2,339,500,000 1,170,300,000 701,000,000.0
Cash and cash equivalents, end of period* $ 2,755,700,000 $ 2,339,500,000 $ 1,170,300,000